• Share
  • Email
  • Embed
  • Like
  • Private Content
Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
 

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

on

  • 193 views

The global insulin delivery devices market was valued at $8.8 billion in 2012 and is forecast to reach $13.8 billion by 2019, at a CAGR of 7%. Browse this report: http://mrr.cm/Zim

The global insulin delivery devices market was valued at $8.8 billion in 2012 and is forecast to reach $13.8 billion by 2019, at a CAGR of 7%. Browse this report: http://mrr.cm/Zim

Statistics

Views

Total Views
193
Views on SlideShare
192
Embed Views
1

Actions

Likes
0
Downloads
0
Comments
0

1 Embed 1

http://www.slideee.com 1

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers Presentation Transcript

    • www.MarketResearchReports.com Category : Medical Devices All logos and Images mentioned on this slide belong to their respective owners.
    • www.MarketResearchReports.com Introduction to Report  Launch Date: April 4, 2014  Number of Pages: 121  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 3,500 Price For Site User License: USD 7,000 Price For Global User License: USD 10,500 Delivery Time: Within 24 Hours (During Working Days)
    • www.MarketResearchReports.com About the Report Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers report looks at the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics.
    • www.MarketResearchReports.com Research Findings The global insulin delivery devices market was valued at $8.8 billion in 2012 and is forecast to reach $13.8 billion by 2019, at a CAGR of 7%. Emerging economies such as India and China are expected to grow at the fastest pace during the 2012-2019 forecast period. The use of pre-filled cartridges eliminates the need for insulin reservoirs and reduces the weight of the insulin pump by 25%. Currently, the top two players, Medtronic and Animas Corporation, account for 80% of insulin pump sales in the US. Insulet Corporation, with its flagship insulin pump OmniPod, holds about 15% of the market, while other small players such as Tandem, Asante and Roche hold a combined market share of 5%. The Research estimates, competitive conversions will account for about 60% of the sales generated by new entrants such as Insulet Corporation, Tandem Diagnostics and Asante in the future. Patients who are new to insulin pump therapy will contribute close to 40% of the sales generated by new entrants.
    • www.MarketResearchReports.com Research Findings Continues… The worldwide prevalence of diabetes in 2013 was 381.8 million, and this is projected to increase by 55% to 591.1 million by 2035. It is also estimated that 175 million diabetics remain undiagnosed, which accounts for 46% of all diabetics worldwide. China had a diabetes prevalence of 98.4 million, followed by India with 65.1 million and the US with 24.4 million. At the current rate, diabetes prevalence in China is expected to increase to 142.7 million by 2035, while in India it is expected to rise to 109 million by 2035. In 2013, the US spent $239 billion on diabetes, accounting for 36% of its healthcare expenditure, while China, the country with the highest number of diabetics globally, spent only $38 billion on diabetes, accounting for 7% of its healthcare costs.
    • www.MarketResearchReports.com Research Findings Continues… The study showed that the annual cost of providing insulin pumps was projected from $8.6 billion in 2012 to $15.1 billion by 2032. The annual cost of treatment for serious complications from diabetes was projected from $8.8 billion in 2012 to $25.1 billion by 2032. These are the direct costs related to the management of serious complications from diabetes. Considering only the direct costs, government investment in insulin pumps could save $200,000 in 2012 and $10 billion by 2032. Taking indirect costs into account, such as costs associated with mortality and disability arising from diabetes, the net savings will increase to $800,000 in 2012 and $10.8 billion by 2032.
    • www.MarketResearchReports.com Report Coverage Table of Contents Introduction Diabetes – Disease Overview Diabetes – Epidemiology Global Insulin Delivery Devices Market: Device Overview Global Insulin Delivery Devices Market: Market Characterization Global Insulin Delivery Devices Market: Segment Analysis and Forecasts Global Insulin Delivery Devices Market: Country Analysis and Forecasts Global Insulin Delivery Devices Market: Reimbursement System Global Insulin Delivery Devices Market: Competitive Landscape Global Insulin Delivery Devices Market: Product Pipeline Analysis Global Insulin Delivery Devices Market: Consolidation Landscape Appendix
    • www.MarketResearchReports.com Company Coverage 1. Novo Nordisk (Subsidiary of Novo A/S) 2. Sanofi 3. Eli Lilly 4. Medtronic 5. Becton, Dickinson and Company 6. Animas 7. F. Hoffmann-La Roche 8. Insulet 9. Asante Solutions 10. Abbott Laboratories 11. Ypsomed 12. Owen Mumford 13. Bioject Medical Technologies 14. Injex - Equidyne Systems 15. Antares Pharma 16. Tandem Diabetes Care 17. Tonghua Dongbao Pharmaceutical 18. Shanghai Fosun Pharmaceutical
    • www.MarketResearchReports.com Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center
    • www.MarketResearchReports.com How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://mrr.cm/Zim About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +1 302-703-7787 (USA) +91-8762746600 (India)